Advertisement

What affects myelodysplastic/myeloproliferative disease prognosis?

Many factors determine the prognosis of myelodysplastic/myeloproliferative disorders. Blasts are blood cells that have not fully matured. The relative amount of these cells in the bone marrow or blood helps to determine the prognosis of chronic myelomonocytic leukemia. The presence of anemia is another prognostic factor. Prognosis of juvenile myelomonocytic leukemia is affected by age and the number of blood platelets. Atypical chronic myeloid leukemia prognosis is determined by the platelets and red blood cells in the peripheral circulation.

Continue Learning about Hematologic/Blood Cancers

Why Remission Doesn’t Mean Treatment Is Over
Why Remission Doesn’t Mean Treatment Is Over
Despite huge advances in treatment protocols in recent years, multiple myeloma remains, unfortunately, an incurable disease. What does that mean for p...
Read More
Multiple Myeloma is More Common in African Americans: Here’s What You Need To Know
Multiple Myeloma is More Common in African Americans: Here’s What You Need To Know
Multiple myeloma, a cancer that occurs in white blood cells, is considered a rare disease because it makes up a tiny amount of overall cancers. But it...
Read More
Are there alternative therapies for hematologic cancers?
Honor Society of Nursing (STTI)Honor Society of Nursing (STTI)
In addition to conventional therapy with chemotherapy, radiotherapy, stem cell transplant, and immun...
More Answers
Who gets myelodysplastic/myeloproliferative diseases?
Sigma NursingSigma Nursing
Different myelodysplastic/myeloproliferative disease subtypes affect different populations. Men aged...
More Answers

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.